Grifols (Grifols) Operating Cash Flow per Share : $0.00 (TTM As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Grifols Operating Cash Flow per Share?

Grifols's operating cash flow per share for the three months ended in Dec. 2023 was $0.00. Grifols's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -42.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Grifols's Operating Cash Flow per Share or its related term are showing as below:

GIKLY' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -42.6 Med: 9.6 Max: 67.9
Current: -42.6

During the past 13 years, Grifols's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.90% per year. The lowest was -42.60% per year. And the median was 9.60% per year.

GIKLY's 3-Year OCF Growth Rate is ranked worse than
93.18% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs GIKLY: -42.60

Grifols Operating Cash Flow per Share Historical Data

The historical data trend for Grifols's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Operating Cash Flow per Share Chart

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.46

0.99

0.50

-0.01

0.17

Grifols Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Grifols's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, Grifols's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Grifols's Price-to-Operating-Cash-Flow falls into.

Grifols Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Grifols's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	227.135	/	1359.513
	=	0.17

Grifols's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	0	/	1358.185
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Grifols Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Grifols's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols (Grifols) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (OTCPK:GIKLY) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

GIFOF:USA GIFLF:USA GRFS:USA GRFP:Mexico GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain OZTA:Germany

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.